Insider · CIK 0001322959
Kenneth C Cundy
Files at ANEB (Anebulo Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Kenneth C Cundy files SEC Form 4 as officer at ANEB (Anebulo Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kenneth C Cundy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +115,037 | $0.00 | $0 | 115,037 | Apr 7, 2025 |
Questions about Kenneth C Cundy
Answered from the filings on this page, as of the latest one.
Is Kenneth C Cundy buying or selling?
Kenneth C Cundy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kenneth C Cundy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenneth C Cundy has 0.
Where does Kenneth C Cundy file Form 4?
Kenneth C Cundy has filed Form 4 at ANEB (Anebulo Pharmaceuticals, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.